Stanford School of Medicine

Martin S. Angst

  • Associate Professor - Med Center Line, Anesthesia

Contact Information

  • Clinical Offices
    Anesthesia 300 Pasteur Dr S276A MC 5117 Stanford, CA 94305
    Telephone Work (650) 498-5109 Fax (650) 725-8052
  • Academic Offices
    Personal Information
    Email ang@stanford.edu
    Administrative Contact
    Jenny Hu Administrative Associate Tel Work (650) 723-9896
    Not for medical emergencies or patient use

Clinical Focus

  • Anesthesia
  • Anesthesia for Liver Transplantation
  • Neuroanesthesia

Professional Education

  • SUMC - Graduate Medical Education (1996) CA
  • University of Bern - Switzerland (1994) Switzerland
  • Regionalspital Burgdorf (1990) Switzerland
  • Board Certification: Anesthesia, European Board of Anesthesiologists
  • Berne University School of Medicine (1987) Switzerland

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

  • Consulting: Cortex Pharmaceuticals Inc., Gowling Lafleur Henderson LLP, Sidley Austin LLP, Trigemina INc., Vertex Pharmaceuticals LLC
  • Royalty Payments: Trigemina INc.
  • Equity: Cytonics Inc., Trigemina INc.

Research Interests

The human pain research laboratory was launched in 1995 as a translational research unit assisting the transfer of knowledge between basic and clinical sciences. Engaged in a bidirectional approach the lab is well positioned to examine how findings in the basic sciences apply to human biology, and to explore the validity and mechanistic implications of intriguing clinical observations under well controlled, “bench-like” conditions.

Our laboratory is active in three major and inter-related areas: the identification of pain biomarkers and potential analgesic targets, the early validation or rejection of novel analgesic interventions, and the pharmacogenomics and proteomics of opioid-analgesics. Pertinent questions are addressed with aid of experimental and clinical pain models (e.g. calibrated sunburns or surgical wounds), pharmacological tools (e.g. computer-controlled infusion algorithms), proteomic and genomic approaches (e.g. micro-catheter based techniques for tissue-specific sampling and analysis of cytokine and chemokine profiles), and imaging techniques (e.g. laser doppler imaging). The overarching goal of our research is to move towards a mechanism-based and individualized diagnosis and therapy of pain.

Publications